Alpha Tau Medical Ltd.
DRTS
$2.61
-$0.03-1.14%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | 11.74% | -1.13% | -5.83% | -11.02% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 3.33% | 10.85% | 24.52% | 21.30% | |
| Operating Income | -3.33% | -10.85% | -24.52% | -21.30% | |
| Income Before Tax | -28.78% | 15.01% | -116.83% | -89.40% | |
| Income Tax Expenses | -75.00% | -88.46% | 166.67% | -533.33% | |
| Earnings from Continuing Operations | -28.66% | 15.23% | -116.87% | -87.27% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -28.66% | 15.23% | -116.87% | -87.27% | |
| EBIT | -3.33% | -10.85% | -24.52% | -21.30% | |
| EBITDA | -3.35% | -10.89% | -24.99% | -22.02% | |
| EPS Basic | -27.57% | 15.87% | -115.68% | -85.83% | |
| Normalized Basic EPS | -27.69% | 15.62% | -115.31% | -- | |
| EPS Diluted | -27.57% | 15.87% | -115.68% | -85.83% | |
| Normalized Diluted EPS | -27.69% | 15.62% | -115.31% | -- | |
| Average Basic Shares Outstanding | 0.82% | 0.79% | 0.57% | 0.90% | |
| Average Diluted Shares Outstanding | 0.82% | 0.79% | 0.57% | 0.90% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |